FDA
-
-
-
-
-
-
-
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
-
-
-
-
-
-
-
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
-
-
-
-
-
-
-
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025
-
-
-
-
-
-
-
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
-
-
-
-
-
-
-
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
-
-
-
-
-
-
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

